Amit Chowdhry is a Co-Founder & Editor in Chief at his own media outlet. He covers a diverse range of topics including finance, investment, technology, and energy sustainability, with a focus on financial platforms, digital health, and software development. Amit has been featured in Online Personals Watch, Pulse 2.0, and CFP Board.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Amit Chowdhry's articles predominantly cover press releases and private sector announcements related to investment, technology, funding, business, and startups. His focus is on software & SaaS and healthcare & pharmaceutical industries.
Given the high percentage of press release coverage in his articles, Amit may be particularly interested in receiving pitches from PR representatives or individuals with direct knowledge of significant developments within the software & SaaS and healthcare sectors.
He appears to take an industry-wide perspective rather than a specific geographic one based on the topics covered. This suggests that he would be open to hearing about companies making waves in these sectors regardless of their location.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Amit Chowdhry
Glucotrack has entered into definitive agreements for approximately $5.5 million in financing from institutional investors. The deal consists of a $2 million equity financing and a $3.5 million follow-on investment in the form of convertible debt.
By: Amit Chowdhry
Opal Therapeutics has secured a $1.25 million Phase II award through the National Science Foundation's Small Business Innovation Research program.
Sapiom has raised $35 million in Series A funding to expand its infrastructure platform for deploying, operating and scaling artificial intelligence agents.
Vedanta Biosciences has secured $60 million in funding to advance its pivotal Phase 3 RESTORATiVE303 study evaluating VE303 for the prevention of recurrent Clostridioides difficile infection. The financing includes a $40 million investment round led by existing investors AMR Action Fund and BNP Paribas Asset Management Alts. Vedanta received approximately $18 million during the first quarter and another $22 million during the second quarter.
By: Amit Chowdhry
Proxy Foods AI has raised $6 million in seed funding to expand its artificial intelligence platform for food and beverage research and development. The round was led by Ted Leonsis, founder, chairman, managing partner and CEO of Monumental Sports & Entertainment, with lead participation from Robert G. Hisaoka and SWaN & Legend Venture Partners.
By: Amit Chowdhry
LifeMine Therapeutics has secured $263 million in financing to accelerate the clinical development of LIFE-001 and advance its broader pipeline of transplantation and immunology therapies. The financing includes an oversubscribed $188 million Series E round led by Milky Way Investments. New investors included Bezos Expeditions, Gates Frontier and RA Capital Management, while GV, LoLa Capital Partners, GlaxoSmithKline, Invus and ARCH Venture Partners continued their support.
By: Amit Chowdhry
Paycom Software delivered stronger-than-expected second-quarter 2026 earnings as recurring revenue growth, margin expansion, lower research spending, and a substantially reduced share count supported higher profitability.
By: Amit Chowdhry
Nextalia has completed the first close of Nextalia Private Equity II at more than €1.1 billion, securing commitments from over 200 investors within five months.
By: Amit Chowdhry
Procter & Gamble has announced plans to acquire Thorne, a science-driven wellness company known for dietary supplements and personalized health solutions supported by healthcare practitioners.
By: Amit Chowdhry
UWM Holdings announced a $2.05 billion equity capital investment from Oaktree Capital Management and an investment vehicle owned by the Ishbia family as the mortgage lender moves to strengthen liquidity and reduce balance-sheet pressure.
